You are here: University of Sydney / Faculty of Pharmacy / Academic Staff / Professor Jo-anne Brien 

Professor Jo-anne Brien

BPharm BS (Pharm), PharmD, FRPharmS
Professor of Clinical Pharmacy (St Vincent's Hospital)

A15 - Pharmacy And Bank Building
The University of Sydney

Telephone +61 2 9351 2363
Fax +61 2 9351 4391

Biographical details

Professor Jo-anne Brien holds the inaugural chair in Clinical Pharmacy (St Vincent’s Hospital) at the University of Sydney since 2000. She is also a Conjoint Professor of Medicine at the St Vincent’s Hospital Clinical School, UNSW. After working in Oncology Pharmacy in Sydney, Professor Brien undertook postgraduate clinical research training in the United States, working in academic research units with a focus on pharmacokinetics in cancer and returned to an academic appointment at Monash University.

Professor Brien is Chair of the St Vincent’s Hospital Human Research Ethics Committee and Deputy Chair of the St Vincent’s Hospital Drug and Therapeutics Committee. She is a member of the Management Committee of the NSW Therapeutic Advisory Group (NSWTAG) and has served as a member of the Drug Utilisation Sub-Committee (DUSC) of PBAC, Chairman of the NSW Branch of Society of Hospital Pharmacists Australia. Jo-anne has been Associate Editor for the Journal of Oncology Pharmacy Practice, and was Editor in Chief of the Journal of Pharmacy Practice and Research from 2006 to 2013.
In 2006 Jo-anne was awarded the ‘Best Consultant Tutor’ in the St Vincent’s Clinical School, and in 2008 was awarded the SHPA GSK Medal of Merit. Professor Brien has supervised 35 postgraduate research students in the areas of Quality Use of Medicines and Health Services research.

Back to Top

Research interests

  • Clinical Pharmacy
  • Health Services Research
  • Drug Access and Policy
  • Quality Use of Medicines

Back to Top

Teaching and supervision

HIgher Degree Research Candidates:

  • Garrett, Timothy S
    Doctor of Philosophy, part time
    Start: February 2008
    Submit: February 2016
  • Laba (nee Hargaves), Tracey-Lea
    Doctor of Philosophy
    Start: February 2008
    Submit: February 2014
  • Sinha, Yashwant, K
    Doctor of Philosophy, part time
    Start: February 2006
    Submit:July 2013

Back to Top

Associations

National
Australian Pharmacy Council, Examining Committee (member)

State
NSW Therapeutics Advisory Group (NSWTAG) Management Committee (member)
Justice Health, Ethics and Human Research Committee (Chair)

St Vincent's Hospital
St Vincent's Hospital Human Research Ethics Committee (Chair)
St Vincent's Hospital Drug and Therapeutics Committee (Deputy Chair)
St Vincent's and Mater Health, Bioethics Committee (member)
Conjoint Professor, St Vincent's Clinical School, St Vincent's Hospital (UNSW)

Professional and Academic Services
Editor in Chief, Journal of Pharmacy Practice and Research (2006-2013)
Editorial Advisory Boards: International Journal of Pharmacy Practice
Clinical Case reports Strategic Advisory Board

Back to Top

Selected grants

2011

  • What Determines Patients Adherence to Treatment in Cardiovascular Disease Prevention? A Process Evaluation of The Kanyini-GAP Trial; Jan S, Rose J, Usherwood T, Brien J, Peiris D, Rose J, Hayman N, Howard K; National Health and Medical Research Council/Project Grants.

2008

  • Varian 400 Mhz Spectrometer + Autosampler, installtion costs incl Liquid Helium, Compressor System and Air Dryer; Brien J; Clive & Vera Ramaciotti Foundation/Equipment Grant.

2006

  • Quality Indicators for Best Practice Approaches to Experiential Placements in Pharmacy programs.; Hotham L, Davey A, McLachlan A, Brien J, Chaar B, Stupans I, March G, McAteer S; Carrick Institute of Teaching and Learning/Discipline Initiative Grant.

2005

  • Exploring The Influence Of Cultural And Social Factors In Two Teaching Hospitals On The Prescribing Process And How Doctors Learn To Prescribe; Brien J, Bajorek B, Page M; Society of Hospital Pharmacists of Australia/Research and Development Grants Program.
  • Professional ethics in Pharmacy.; Brien J, Chaar B, Krass I; Pharmacy Board of NSW/Education and Research Grant.
  • Evaluation of the "RIME" protocol as an assessment tool for students involved in multidisciplina; Segelov E, Grabs A, Magney A, Neil M, Fallon A, Bloomfield L, Brien J, Joo Leow L; University of New South Wales/Learning and Teaching Grant.

2004

  • Access to equity to high cost medications (HCMs): decision-makers perspectives; Brien J; Society of Hospital Pharmacists of Australia/Research Grant.

2003

  • Medication management and education of osteoarthritis patients: evaluation of a role for community pharmacists; Chen T, Day R, Gelgor L, Bajorek B, Day R, Brien J; Pharmacy Guild of Australia/Research Grant.
  • From hospital to community: a multidisciplinary continuity of care model for cardiovascular patients involving community pharmacists; Whitehead P, Chen T, Brien J; Pharmacy Guild of Australia/Research Grant.
  • Putting evidence into practice : implementing Drug Therapy Committee (DTC) policy; Brien J; Society of Hospital Pharmacists of Australia/Research Grant.

2002

  • Quality Assurance in the Clinical Pharmacy Practice Placement Program; Armour C, Aslani P, Brien J, Chen T, Moles R, Sainsbury E, Whitehead P; Quality Teaching Improvement Fund/Contract.
  • Professional pharmacy service to private hospitals; Benrimoj S, Moles R, Brien J; Pharmacy Guild of Australia/Research Grant.
Back to Top

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Lehnbom, E., McLachlan, A., Brien, J. (2012). A qualitative study of Australians' opinions about personally controlled electronic health records. Studies in Health Technology and Informatics, 178, 105-110.
  • Laba, T., Brien, J., Jan, S. (2012). Understanding rational non-adherence to medications. A discrete choice experiment in a community sample in Australia. BMC Family Practice, 13, 1-10.
  • Chaar, B., Brien, J., Hanrahan, J., McLachlan, A., Penm, J., Pont, L. (2011). Experimental Education in Australian Pharmacy: Preceptors' Perspectives. Pharmacy Education, 11(1), 166-171.
  • Yen, L., Gillespie, J., Jeon, Y., Kljakovic, M., Brien, J., Jan, S., Lehnbom, E., Pearce-Brown, C., Usherwood, T. (2011). Health professionals, patients and chronic illness policy: a qualitative study. Health expectations : an international journal of public participation in health care and health policy, 14(1), 10-20.
  • Gallego, G., Taylor, S., Brien, J. (2011). Setting priorities for high-cost medications in public hospitals in Australia: should the public be involved? Australian Health Review, 35(2), 191-196.
  • Jan, S., Usherwood, T., Brien, J., Peiris, D., Rose, J., Hayman, N., Howard, K., Redfern, J., Laba, T., Cass, A., Patel, A. (2011). What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study. BMJ Open, 1(2), e000372-1-e000372-7.
  • Lehnbom, E., Brien, J. (2010). Challenges in chronic illness management: a qualitative study of Australian pharmacists' perspectives. Pharmacy World and Science, 32(5), 631-636.
  • Sinha, Y., Craig, J., Barclay, P., Taitz, J., South, M., Coulthard, K., Pearson, C., Erickson, S., Brien, J. (2010). Drug approval processes in Australian Paediatric Hospitals. Archives of Disease in Childhood, 95(9), 739-744.
  • Gallego, G., Taylor, S., Brien, J. (2009). Funding and access to high cost medicines in public hospitals in Australia: Decision-makers' perspectives. Health Policy, 92(1), 27-34.
  • Lehnbom, E., Welch, S., Ludington, J., Bryant, W., Brien, J. (2009). Impact of a New Insulin Chart on Hospitalised Patients with Diabetes. Journal of Pharmacy Practice and Research, 39(1), 45-49.
  • Lehnbom, E., Boxall, A., Russell, L., Brien, J. (2009). Management of Medicines in Chronic Illness: Views of Community Pharmacists in New South Wales. Journal of Pharmacy Practice and Research, 39(3), 207-210.
  • Chaar, B., Brien, J., Krass, I. (2009). Professional ethics in pharmacy practice: developing a psychometric measure of moral reasoning. Pharmacy World and Science, 31(4), 439-449.
  • Sweidan, M., Reeve, J., Brien, J., Jayasuriya, P., Martin, J., Vernon, G. (2009). Quality of drug interaction alerts in prescribing and dispensing software. Medical Journal of Australia, 190(5), 251-254.
  • Ellitt, G., Brien, J., Aslani, P., Chen, T. (2009). Quality Patient Care and Pharmacists' Role in Its Continuity - A Systematic Review. The Annals of Pharmacotherapy, 43(4), 677-691.
  • Sinha, Y., Brien, J., Craig, J. (2009). The pharmaceutical benefits scheme and implications for paediatric prescribing. Journal of Paediatrics and Child Health, 45(6), 351-357.
  • Hargraves, T., Bennett, A., Brien, J. (2008). Developing an Outpatient Heart Failure Pharmacy Service. Journal of Pharmacy Practice and Research, 38(2), 103-106.
  • Brien, J. (2008). Keeping up with the evidence, trials and journals. Journal of Pharmacy Practice and Research, 38(2), 91-91.
  • O'Brien, R., Aslani, P., Ciccia, M., Brien, J. (2008). Medication adherence among heart and/or lung transplant recipients: An exploratory study. Patient Preference and Adherence, 2, 115-120.
  • Brien, J. (2008). Pharmacogenetics and the future of clinical pharmacy practice. Journal of Pharmacy Practice and Research, 38(1), 7-7.
  • Page, M., Bajorek, B., Brien, J. (2008). Prescribing in Teaching Hospitals: a Qualitative Study of Social and Cultural Dynamics. Journal of Pharmacy Practice and Research, 38(4), 286-291.
  • Brien, J. (2008). What is ethical research? Journal of Pharmacy Practice and Research, 38(3), 178-178.
  • Moles, R., Brien, J., Benrimoj, S. (2007). New South Wales Private Hospitals and their Pharmacy Services. Journal of Pharmacy Practice and Research, 37(2), 115-119.
  • Gallego, G., Taylor, S., Brien, J. (2007). Priority setting for high cost medications (HCMs) in public hospitals in Australia: A case study. Health Policy, 84(1), 58-66.
  • Gallego, G., Taylor, S., Brien, J. (2007). Provision of pharmaceuticals in Australian hospitals: equity of access? Pharmacy World and Science, 29(2), 47-50.
  • Gallego, G., Taylor, S., McNeill, P., Brien, J. (2007). Public views on priority setting for High Cost Medications in public hospitals in Australia. Health expectations : an international journal of public participation in health care and health policy, 10(3), 224-235.
  • Brien, J. (2006). Clinical governance. Journal of Pharmacy Practice and Research, 36(3), 174-174.
  • Hargraves, T., Bennett, A., Brien, J. (2006). Evaluating outpatient pharmacy services: a literature review of specialist heart failure services. International Journal of Pharmacy Practice, 14(1), 3-9.
  • Brien, J. (2006). Evidence-Based Practice. Journal of Pharmacy Practice and Research, 36(2), 94-95.
  • Brien, J. (2006). Pharmaceutical Review- A View from academia. Journal of Pharmacy Practice and Research, 36(4), 256-256.
  • Kay, O., Bajorek, B., Brien, J. (2006). Pharmacist Prescribing Activities - An electronic survey on the opinions of Australian pharmacists from three pharmacy organisations. Journal of Pharmacy Practice and Research, 36(3), 199-203.
  • Brien, J. (2006). Planning the future. Journal of Pharmacy Practice and Research, 36(1), 10-10.
  • Tan, E., Day, R., Brien, J. (2006). Prioritising drug and therapeutics committee (DTC) decisions: a national survey. Pharmacy World and Science, published online 23 dec 2006 DOI 10.1007/s11096-00(29 (2007)), 90-96.
  • Gallego, G., Melocco, T., Taylor, S., Brien, J. (2005). Access to high cost drugs: decision makers' perspectives. Journal of Pharmacy Practice and Research, 35(1), 18-20.
  • Maxwell, D., Easton, K., Brien, J., Kaye, K. (2005). Antibiotic guidelines in NSW hospitals. Australian Health Review, 29(4), 416-421.
  • Bennett, A., Brien, J., Macdonald, P. (2005). Barriers To Diagnosing And Managing Heart Failure In Primary Care. Medical Journal of Australia, 182(6), 309-309.
  • Slader, S., Welch, S., Finckh, A., Brien, J. (2005). Evaluation of a weight-based heparin dosing protocol. Journal of Pharmacy Practice and Research, 35(1), 15-17.
  • Tan, E., Day, R., Brien, J. (2005). Perspectives on Drug and Therapeutics Committee policy implementation. Research in Social and Administrative Pharmacy, 1(4), 526-545.
  • Chaar, B., Brien, J., Krass, I. (2005). Professional ethics in pharmacy: the Australian experience. International Journal of Pharmacy Practice, 13, 195-204.
  • Hamama, A., Ray, J., Day, R., Brien, J. (2005). Simultaneous determination of rofecoxib and celecoxib in human plasma by high-performance liquid chromatography. Journal of Chromatographic Science, 43(7), 351-354.
  • Brien, J., Hall, W., Ward, R., Liauw, W., Lu, C. (2005). Tailoring access to high cost, genetically targeted drugs. Medical Journal of Australia, 182(12), 607-608.
  • Bennett, A., Krass, I., Brien, J. (2005). The future burden of cardiovascular disease: what can pharmacists do? Australian Journal of Pharmacy, 86(1020), 166-169.
  • Gilbar, P., Dooley, M., Brien, J. (2004). Editorial: Inadvertent intrathecal administration of vincristine: are we fulfilling our roles as oncology pharmacists? Journal of Oncology Pharmacy Practice, 10(4), 187-189.
  • Kay, O., Brien, J. (2004). editorial: Pharmacist prescribing - Lessons from abroad. Journal of Pharmacy Practice and Research, 34(4), 259-261.
  • Sabet, P., Maxwell, D., Brien, J. (2004). Evaluation Of Mycophenolate For Unregistered Indications. Journal of Pharmacy Practice and Research, 34(1), 36-38.
  • Cocks, H., Kevans, P., Graham, R., Brien, J. (2004). Evaluation Of Therapeutic Drug Monitoring Services And Comparison Of Two Models Of Service Provision. Journal of Pharmacy Practice and Research, 34(2), 109-113.
  • Moles, R., Brien, J., Benrimoj, S. (2004). Factors influencing pharmaceutical service provision within NSW private hospitals. Australian Pharmacist, 23(3), 238-243.
  • Easton, K., Chapman, C., Brien, J. (2004). Frequency And Characteristics Of Hospital Admissions Associated With Drug-Related Problems In Paediatrics. British Journal of Clinical Pharmacology, 57(5), 611-615.
  • Gallego, G., Melocco, T., Taylor, S., Brien, J. (2004). Impact Of High Cost Drugs For Individual Patient Use. Journal of Pharmacy Practice and Research, 34(2), 100-103.
  • Lawler, C., Welch, S., Brien, J. (2004). Omitted Medication Doses: Frequency And Severity. Journal of Pharmacy Practice and Research, 34(3), 174-177.
  • Kay, O., Brien, J. (2004). Pharmacist prescribing: Review of the literature. Journal of Pharmacy Practice and Research, 34(4), 300-304.
  • Whitehead, P., Armour, C., Aslani, P., Brien, J., Chen, T., Loh, M., Sainsbury, E. (2004). Research Into Teaching: Quality Assurance In Clinical Placements. Australian Journal of Pharmacy, 85(1008), 166-169.
  • Tan, E., Day, R., Brien, J. (2004). Stakeholder Opinions On The Implementation Of Drug And Therapeutics Committee Decisions. Journal of Pharmacy Practice and Research, 34(3), 178-182.
  • Easton-Carter, K., Chapman, C., Brien, J. (2003). Adverse drug reactions in paediatrics: are we getting the full picture? Journal of Pharmacy Practice and Research, 33(2), 106-110.
  • Tan, E., Day, R., Brien, J. (2003). Drug and therapeutics committees - are they fulfilling their potential to improve the quality use of medicines? International Journal of Pharmacy Practice, 11(3), 175-181.
  • Easton-Carter, K., Chapman, C., Brien, J. (2003). Emergency department attendances associated with drug-related problems in paediatrics. Journal of Paediatrics and Child Health, 39(2), 124-129.
  • Tan, E., Day, R., Brien, J. (2003). Improving decision outcomes of drug and therapeutics committees. Journal of Pharmacy Practice and Research, 33(1), 65-67.
  • Brien, J. (2003). Pharmacogenomics - clinical and social implications. Journal of Pharmacy Practice and Research, 33(3), 224-227.
  • Chaar, B., Brien, J., Krass, I. (2003). Professional ethics in pharmacy. Australian Journal of Pharmacy, 84, 856-859.
  • Bennett, A., Brien, J. (2002). Community liaison pharmacist role in the multi-disciplinary care of heart failure patients. Australian Journal of Pharmacy, 83, 740-743.
  • Easton-Carter, K., Chapman, C., Brien, J. (2002). Issues in the interpretation and design of studies investigating drug-related morbidity and mortality. Journal of Pharmacy Practice and Research, 32(3), 235-239.
  • Carapetis, J., jaquiery, A., Buttery, J., Starr, M., Hogg, G., Woods, S., Cranswick, N., Kohn, S., Brien, J., Grimwood, K. (2001). A randomised, controlled trial of once-daily gentamicin in children with urinary tract infections. The Pediatric Infectious Disease Journal, 20(3), 240-246.
  • Bennett, A., Brien, J. (2001). Advances in heart failure management: a review of recent research and a future role for pharmacists. Part 1. Australian Journal of Pharmacy, 82, 716-719.
  • Bennett, A., Brien, J. (2001). Advances in heart failure management: a review of recent research and a future role for pharmacists. Part 2. Australian Journal of Pharmacy, 82, 830-835.

Conferences

  • Aslani, P., Hogan, A., Brien, J., Karamy, R., Bonney, M. (2012). Factors that affect adherence to nebulised medications in patients with cycstic fibrosis. Primary Health Care (PHC) Research Conference (2012), South Australia: Primary Health Care Research and Information Service.
  • Aslani, P., Hogan, A., Brien, J., Bonney, M., Karamy, R. (2011). Nebulised medicine adherence and factors that affect adherence in patients with cystic fibrosis. Australasian Pharmaceutical Science Association (2011), Unkown.
  • Chaar, B., Brien, J., Krass, I. (2006). Developing an instrument for measuring moral reasoning and professional ethics in pharmacy.
  • Bennett, A., Selim, L., Brien, J. (2006). Discharge evidence based medicine use after percutaneous coronary intervention. Asia Pacific Interventional Advances.
  • Selim, L., Bennett, A., Brien, J. (2006). Evidence based medicine use in a high risk cardiovascular population. Australasian Pharmaceutical Sciences Association Annual Meeting.
  • Welander, L., Bennett, A., Brien, J. (2006). Loop diuretic and spironolactone usage in hospitalised patients: A descriptive study. Society of Hospital Pharmacists of Australia, New South Wales State Branch Conference 'Mind the Gap'.
  • Bennett, A., Macdonald, P., Brien, J. (2006). Optimising medication management in cardiac patients: the impact of a specialist pharmacist. Heart Foundation Conference and Scientific Meeting.
  • Selim, L., Bennett, A., Brien, J. (2006). Quality Use of Medicines in a high risk cardiovascular population. Society of Hospital Pharmacists of Australia, New South Wales State Branch Conference 'Mind the Gap'.
  • Chaar, B., Brien, J., Krass, I. (2006). The role of moral reasoning in the processes of decision making and professional ethics in the Quality Use of Medicines (QUM) and pharmacy. National Medicines Symposium 2006, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Gallego, G., Taylor, S., Brien, J. (2006). The role of the public in setting priorities in health care - high cost medications (HCMs) as a case study. Emerging Health Policy Conference,.
  • Bennett, A., Macdonald, P., Brien, J. (2006). The specialist cardiovascular pharmacist in chronic heart disease: an Australian perspective. European Society for Clinical Pharmacy. Vilnius,.
  • Moles, R., Brien, J., Benrimoj, S. (2005). A medication education service (MES) provided to private hospital patients at discharge. Society of Hospital Pharmacists of Australia Federal Conference.
  • Bennett, A., Jones, G., Macdonald, P., Brien, J. (2005). Additional benefits of follow-up NT-proBNP measurements in ambulatory heart failure patients after hospital discharge. Heart Failure Society of America.
  • Bennett, A., Hayward, C., Macdonald, P., Brien, J. (2005). Amiodarone-induced thyrotoxicosis (AIT): a challenge in heart failure (HF) patients. Society of Hospital Pharmacists of Australia Federal Conference.
  • Bennett, A., Jones, G., Macdonald, P., Brien, J. (2005). Comparison of BNP and NT-proBNP in prognostic determination of heart failure patients. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand.
  • Lehnbohn, E., Welch, S., Brien, J. (2005). Evaluation of a new insulin medication chart. Society of Hospital Pharmacists of Australia Federal Conference.
  • Gallego, G., Taylor, S., Brien, J. (2005). Paying for medicines used in hospitals in Australia. Federation Internationale Pharmaceutique (2005).
  • Jones, E., Brien, J. (2005). Student assessment in clinical placements. Pharmacy Education Symposium.
  • Bennett, A., Jones, G., Macdonald, P., Brien, J. (2005). Within subject biological variation of N-terminal proB-type natriuretic peptide (NT-proBNP) in stable heart failure patients. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand.
  • Moles, R., Brien, J., Benrimoj, S. (2004). A new Australian private hospital pharmacy service. Pharmacy and Pharmaceutical Sciences World Congress, 63rd Congress of Federation Internationale Pharmaceutique,.
  • Hamama, A., Ray, J., Liauw, W., Day, R., Brien, J. (2004). A population pharmacokinetics study of celecoxib and rofecoxib: a preliminary data analysis. Fourth Research Conference 2004 "From Cell to Society 4", Sydney: Faculties of Health, University of Sydney.
  • Hamama, A., Ray, J., LIAUW, W., Day, R., Brien, J. (2004). A population pharmacokinetics study of celecoxib and rofecoxib: preliminary model building. 2004 Australian Health and Medical Research Conference, Balnarring, Vic?: The Australian Health and Medical Research Congress.
  • Tan, E., Brien, J., Day, R. (2004). A qualitative investigation of Drug and Therapeutics Committee (DTC) policy implementation. 33rd European Symposium on Clinical Pharmacy: Risk Management in Pharmacotherapy.
  • Page, M., Bakorek, B., Brien, J. (2004). A qualitative study to explore influences on prescribing and how doctors learn to prescribe within teaching hospitals. Fourth Research Conference 2004 "From Cell to Society 4", Sydney: Faculties of Health, University of Sydney.
  • Gallego, G., Taylor, S., Brien, J. (2004). Access to high cost medicines (HCMs) in public hospitals: What does the general public know?. Australasian Pharmaceutical Science Association Conference, Melbourne, Vic: Australasian Pharmaceutical Science Association.
  • Maxwell, D., Kaye, K., Brien, J., Easton-Carter, K. (2004). Antibiotic guidelines - how far have we come?. National Medicines Symposium 2004 - Quality use of medicines: time for total integration. National Medicines Symposium 2004.
  • Tan, E., Day, R., Brien, J. (2004). Barriers to Drug and Therapeutics Committee (DTC) policy implementation. National Medicines Symposium 2004 - Quality use of medicines: time for total integration. National Medicines Symposium 2004.
  • Jones, G., Bennett, A., Boscato, L., Macdonald, P., Brien, J. (2004). Biological variation of N-Terminal Pro-BNP in Stable Heart failure. 42nd Annual Scientific Conference of the Australasian Association of Clinical Biochemists.
  • Jones, G., Boscato, L., Bennett, A., Macdonald, P., Brien, J. (2004). BNP storage stability and comparison with Pro-BNP in chronic heart failure. 42nd Annual Scientific Conference of the Australasian Association of Clinical Biochemists.
  • Maxwell, D., Kaye, K., Brien, J., Easton-Carter, K. (2004). Community acquired pneumonia: ceftriaxone and penicillin - A global perspective. Clinical Pharmacology and Toxicology World Congress.
  • Gallego, G., Taylor, S., Brien, J. (2004). Decision makers' perceptions of access to high cost drugs (HCDs) in public hospitals in Australia. ISPOR Ninth Annual International Meeting.
  • Gallego, G., Taylor, S., Brien, J. (2004). Decision-makers' perceptions of access to high cost medications (HCMs) in public hospitals. Fourth Research Conference 2004 "From Cell to Society 4", Sydney: Faculties of Health, University of Sydney.
  • Moles, R., Brien, J., Benrimoj, S. (2004). Development of a Medication Education Service for Private Hospital Patients. National Medicines Symposium 2004 - Quality use of medicines: time for total integration. National Medicines Symposium 2004.
  • Tan, E., Day, R., Brien, J. (2004). Drug and Therapeutics Committee (DTC) policy implementation: a qualitative study. 4th SHPA Biennial Clinical Conference.
  • Gallego, G., Taylor, S., Brien, J. (2004). Equity of access to high cost drugs (HCDs): A case study. Clinical Pharmacology and Toxicology World Congress.
  • Brien, J., Taylor, S., Gallego, G. (2004). Equity of access to oncology high cost drugs (HCDs): an Australian perspective. ISOPP IX : The Ninth International Symposium on Oncology Pharmacy Practice.
  • Slader, C., Welch, S., Finckh, A., Brien, J. (2004). Evaluation of a Weight-Based Heparin Dosing Protocol. National Medicines Symposium 2004 - Quality use of medicines: time for total integration. National Medicines Symposium 2004.
  • Bennett, A., Hargraves, T., Macdonald, P., Brien, J. (2004). Evaluation of specialist pharmacy services. National Medicines Symposium 2004 - Quality use of medicines: time for total integration. National Medicines Symposium 2004.
  • Page, M., Bajorek, B., Brien, J. (2004). Exploring the influence of cultural and social factors in two teaching hospitals on the prescribing process and how doctors learn to prescribe. Young Pharmacists Conference.
  • Bennett, A., Macdonald, P., Brien, J. (2004). Importance of pharmacist's role in multi-disciplinary care of heart failure (HF) patients. 4th SHPA Biennial Clinical Conference.
  • Gallego, G., Taylor, S., Melocco, T., Brien, J. (2004). Is equity of access to High Cost Drugs (HCDs) a QUM issue?. National Medicines Symposium 2004 - Quality use of medicines: time for total integration. National Medicines Symposium 2004.
  • Ellitt, G., Aslani, P., Brien, J., Whitehead, P., Ng, K., Chen, T. (2004). Is inter-disciplinary collaboration the answer to continuity of patient care?. From Cell to Society, College of Health Sciences, University of Sydney Research Conference.
  • Page, M., Brien, J., Bajorek, B. (2004). Medication management in teaching hospitals: a review of the role and practice of junior doctors. 4th SHPA Biennial Clinical Conference.
  • Bennett, A., Jones, E., Macdonald, P., Brien, J. (2004). NT-ProBNP as a prognostic marker in heart failure (HF) or risk stratification for HF patients using NT-proBNP. Australasian Pharmaceutical Science Association Conference, Melbourne, Vic: Australasian Pharmaceutical Science Association.
  • Bennett, A., Macdonald, P., Brien, J. (2004). Optimal use of medications in heart failure (HF). Australasian Pharmaceutical Science Association Conference, Melbourne, Vic: Australasian Pharmaceutical Science Association.
  • Kay, O., Brien, J. (2004). Pharmacist prescribing- a review of the literature. 4th SHPA Biennial Clinical Conference.
  • Page, M., Bajorek, B., Brien, J. (2004). Prescribing in teaching hospitals: developing a qualitative instrument to explore influences on decisions and actions. Australasian Pharmaceutical Science Association Conference, Melbourne, Vic: Australasian Pharmaceutical Science Association.
  • Bennett, A., Bardsley,, K., Davidson, P., Macdonald, P., Brien, J. (2004). Quality Use of Medicines (QUM) in heart failure. ANZ Cardiac Society.
  • Bennett, A., Keogh, A., Brien, J. (2004). Ramifications of recent recommendations for high-dose statins: will we see more cases of myopathy?. 4th SHPA Biennial Clinical Conference.
  • Tan, E., Day, R., Brien, J. (2004). Stakeholder opinions of Drug and Therapeutics Committee (DTC) policy implementation strategies. Clinical Pharmacology and Toxicology World Congress.
  • Tan, E., Day, R., Brien, J. (2004). Strategies to implement Drug and Therapeutics Committee (DTC) decisions. Fourth Research Conference 2004 "From Cell to Society 4", Sydney: Faculties of Health, University of Sydney.
  • Bennett, A., Jones, G., Macdonald, P., Brien, J. (2004). Use of NT-proBNP as a prognostic marker in heart failure. From Cell to Society, College of Health Sciences, University of Sydney Research Conference.
  • Tan, E., Day, R., Brien, J. (2004). What makes a decision of a Drug & Therapeutics Committee 'important'?. Australasian Pharmaceutical Science Association Conference, Melbourne, Vic: Australasian Pharmaceutical Science Association.
  • Sabet, P., Maxwell, D., Brien, J. (2003). A DUE of 'off-label' mycophenolate use at St. Vincent's Hospital. Society of Hospital Pharmacists of Australia, 26th Federal Conference.
  • Liao-Loon, H., Trayers, P., Bajorek, B., Brien, J. (2003). A feasibility study for the extension of professional pharmacy services to the Emergency Department of Nepean Hospital, focussing on pharmacist obtained medication histories (PIE study). Australasian Pharmaceutical Science Association Conference 2003, Not published: Icpof.
  • Hamama, A., Ray, J., LIAUW, W., Day, R., Brien, J. (2003). A population pharmacokinetics study of celecoxib and rofecoxib: a preliminary data analysis. Australasian Pharmaceutical Science Association Conference 2003, Not published: Icpof.
  • Gallego, G., Melocco, T., Taylor, S., Brien, J. (2003). Access to high cost drugs in public hospitals: the Australian scenario. Pharmacy and Pharmaceutical Sciences World Congress, 63rd Congress of Federation Internationale Pharmaceutique,.
  • Maxwell, D., Harkness, J., Brien, J. (2003). Antibiotic policy - The path of least resistance. Society of Hospital Pharmacists of Australia, 26th Federal Conference.
  • Gallego, G., Taylor, S., Melocco, T., Brien, J. (2003). Clinical decisions, ethical challenges: the role of a High Cost Drug Subcommittee (HCD). Society of Hospital Pharmacists of Australia, 26th Federal Conference.
  • Tan, E., Day, R., Campbell, T., Melocco, T., Brien, J. (2003). Drug and therapeutics committee (DTC) decision implementation: experiences at a teaching hospital. Pharmacy and Pharmaceutical Sciences World Congress, 63rd Congress of Federation Internationale Pharmaceutique,.
  • Hargraves, T., Bennett, A., Brien, J. (2003). Evaluating specialist pharmacy (heart failure) ambulatory services. Australasian Pharmaceutical Science Association Conference 2003, Not published: Icpof.
  • Bennett, A., Brien, J., Macdonald, P., Bardsley,, K., Gay, T. (2003). Extended role for pharmacy to address continuity of care in chronic disease. Society of Hospital Pharmacists of Australia, 26th Federal Conference.
  • Tan, E., Day, R., Brien, J. (2003). From policy to practice: improving the effectiveness of Drug and Therapeutics Committee (DTC) decision implementation. Society of Hospital Pharmacists of Australia, 26th Federal Conference.
  • Gallego, G., Taylor, S., Melocco, T., Brien, J. (2003). High cost medications & decision makers. What's going on in Australia?. Australasian Pharmaceutical Science Association.
  • Bennett, A., Bardsley,, K., Gay, T., Macdonald, P., Brien, J. (2003). Home-based collaborative model for heart failure (HF) sufferers in Eastern Sydney. St Vincent's Hospital Campus Research Symposium.
  • Moles, R., Brien, J., Benrimoj, S. (2003). M.E.S. - a new private hospital service. Australasian Pharmaceutical Science Association Conference 2003, Not published: Icpof.
  • O'Brien, R., Ciccia, M., Aslani, P., Brien, J. (2003). Medication adherence in heart lung transplant recipients. Society of Hospital Pharmacists of Australia, 26th Federal Conference.
  • Moles, R., Brien, J., Benrimoj, S. (2003). Medication education and medication review services to private hospital patients. Society of Hospital Pharmacists of Australia, 26th Federal Conference.
  • Bennett, A., Bardsley,, K., Macdonald, P., Brien, J. (2003). Providing support for community pharmacists caring for heart failure patients. Pharmacy and Pharmaceutical Sciences World Congress, 63rd Congress of Federation Internationale Pharmaceutique,.
  • Aslani, P., Armour, C., Brien, J., Chen, T., Loh, M., Moles, R., Sainsbury, E., Whitehead, P. (2003). Quality Assurance in Experiential Learning. EdHealth Conference,, sydney: University of Sydney.
  • Armour, C., Aslani, P., Brien, J., Chen, T., Loh, M., Moles, R., Sainsbury, E. (2003). Quality assuring clinical placements. Australasian Pharmaceutical Science Association Conference 2003, Not published: Icpof.
  • Sainsbury, E., Armour, C., Aslani, P., Brien, J., Chen, T., Moles, R., Singh, P., Loh, M., Whitehead, P. (2003). You just won't believe what happened in my placement yesterday! Experiences of a novel clinical placement program in final year pharmacy. Annual meeting of Higher Education Research and Development Society of Australasia, notk known.
  • Whitehead, P., Loh, M., Sainsbury, E., Aslani, P., Brien, J., Chen, T., Moles, R., Singh, P., Armour, C. (2003). You'll never guess what happened in my placement yesterday. Vice-Chancellor's teaching and learning showcase of scholarly reflection and inquiry.
  • Hamama, A., Day, R., Brien, J., Ray, J. (2002). An innovative assay for the simultaneous quantitation of rofecoxib and celecoxib in human plasma. Annual Conference of the Australasian Pharmaceutical Science Association. Australasian Pharmaceutical Science Association.
  • Moles, R., Benrimoj, S., Brien, J. (2002). Census of pharmacy models and services in New South Wales private hospitals. Society of Hospital Pharmacists of Australia, NSW State Branch Conference. The Society of Hospital Pharmacists of Australia.
  • Tan, E., Day, R., Brien, J. (2002). Current principle functions of drugs and therapeutics committees. 12th International Social Pharmacy Workshop, Sydney: Faculty of Pharmacy, University of Sydney.
  • Bennett, A., Brien, J., Macdonald, P., Bardsley,, K., Jones, G., Hayward, C., Keogh, A., Campbell, T. (2002). Identification and management of high risk heart failure patients using BNP. 12th St Vincent's and Mater Health Research Conference, Sydney Australia.
  • Tan, E., Brien, J., Day, R. (2002). Implementation of Drug and Therapeutics Committee decisions: interventions to influence prescribing. Annual Conference of the Australasian Pharmaceutical Science Association. Australasian Pharmaceutical Science Association.
  • Moles, R., Benrimoj, S., Brien, J. (2002). Implementing professional services in NSW private hospitals: work in progress. Society of Hospital Pharmacists of Australia, NSW State Branch Conference. The Society of Hospital Pharmacists of Australia.
  • Bennett, A., Brien, J., Bardsley,, K., Macdonald, P. (2002). Optimisation of heart failure management by pharmacists. Society of Hospital Pharmacists of Australia, NSW State Branch Conference. The Society of Hospital Pharmacists of Australia.
  • Bennett, A., Brien, J., Macdonald, P., Bardsley,, K. (2002). Pharmacist involvement in the multidisciplinary management of heart failure.
  • Moles, R., Benrimoj, S., Brien, J. (2002). Pharmacists' views on implementing professional pharmacy services in NSW private hospitals. 3rd Annual College of Health Science Research Conference, Sydney: University of Sydney.
  • Tan, E., Day, R., Brien, J. (2002). QUM and the Drug Committee: current principle functions of DTCs. Society of Hospital Pharmacists of Australia, NSW State Branch Conference. The Society of Hospital Pharmacists of Australia.
  • Bennett, A., Brien, J., Bardsley,, K., Macdonald, P. (2002). Research opportunities in an innovative service program. Annual Conference of the Australasian Pharmaceutical Science Association. Australasian Pharmaceutical Science Association.
  • Gallego, G., Brien, J., Taylor, S., Melocco, T. (2002). The financial impact of approval of high cost drugs for individual patient use (IPU) at a Sydney teaching hospital. Society of Hospital Pharmacists of Australia, NSW State Branch Conference. The Society of Hospital Pharmacists of Australia.
  • Slader, C., Brien, J. (2002). The graduates forum: supporting new graduates in the transition from university to hospitals. Society of Hospital Pharmacists of Australia, NSW State Branch Conference. The Society of Hospital Pharmacists of Australia.
  • Easton-Carter, K., Brien, J., Kay, K., Mackson, J., Robinson, M., Day, R., New South Wales Therapeutic Assessment Group, D. (2001). A multi-centre drug use evaluation study of proton pump inhibitor prescribing. Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists Conference. World Scientific Publishing.
  • Easton-Carter, K., Kaye, K., Mackson, J., Robinson, M., Brien, J., New South Wales Therapeutic Assessment Group, D. (2001). A multicentre investigation of the prescribing of proton pump inhibitors in hospitals. St Vincent's Hospital Research Symposium.
  • Kaye, K., Easton-Carter, K., Mackson, J., Robinson, M., Day, R., Brien, J. (2001). An Investigation of Hospital Prescribing of Proton Pump Inhibitors. Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists Conference. World Scientific Publishing.
  • Easton-Carter, K., Kaye, K., Mackson, J., Robinson, M., Brien, J., New South Wales Therapeutic Assessment Group, D. (2001). Consistency of proton pump inhibitor prescribing with guidelines: a multicentre drug use evaluation study. Society of Hospital Pharmacists of Australia 25th Federal Conference.
  • Brien, J., Tan, E., Day, R. (2001). Drug and therapeutic committee performance evaluation. Australian Pharmaceutical Science Association Conference, : World Scientific Publishing.
  • Tan, E., Easton-Carter, K., Lawler, C., Jan, D., Mohammed Abdul, M., Melocco, T., Day, R., Brien, J. (2001). Drug committee activities to ensure the quality use of medicines. St Vincent's Hospital Research Symposium.
  • Easton-Carter, K., Kaye, K., Mackson, J., Robinson, M., Brien, J. (2001). Drug Utilisation Support Group. Consistency of proton pump inhibitor prescribing with guidelines: a multicentre drug use evaluation study. Society of Hospital Pharmacists of Australia 25th Federal Conference.
  • Tan, E., Day, R., Melocco, T., Brien, J. (2001). How to assess outcomes of drug and therapeutics committees. Society of Hospital Pharmacists of Australia 25th Federal Conference.
  • Brien, J., Bennett, A., Macdonald, P., Bardsley,, K., Jones, G., Hayward, C., Keogh, A., Campbell, T. (2001). Optimal long term treatment of congestive heart failure (CHF) patients. Australian Pharmaceutical Science Association Conference, : World Scientific Publishing.
  • Easton-Carter, K., Brien, J., Kaye, K., Mackson, J., Robinson, M., Day, R. (2001). Undertaking multicentre drug use evaluation studies: the proton pump inhibitor (PPI) experience. Australian Pharmaceutical Science Association Conference, : World Scientific Publishing.

Report

  • Moles, R., Benrimoj, S., Brien, J. (2005). Professional Pharmacy Services to Private Hospital Patients 2005.
  • Moles, R., Brien, J., Benrimoj, S. (2005). S.I. Professional Pharmacy Services to Private Hospitals.
  • Brien, J., Mant, A., Kaye, K., Kehoe, P. (2002). Evaluation of the implementation and effectiveness of the Australian Pharmaceutical Advisory Committee Guidelines to achieve the continuum of quality use of medicines between hospital and community.

2012

  • Lehnbom, E., McLachlan, A., Brien, J. (2012). A qualitative study of Australians' opinions about personally controlled electronic health records. Studies in Health Technology and Informatics, 178, 105-110.
  • Aslani, P., Hogan, A., Brien, J., Karamy, R., Bonney, M. (2012). Factors that affect adherence to nebulised medications in patients with cycstic fibrosis. Primary Health Care (PHC) Research Conference (2012), South Australia: Primary Health Care Research and Information Service.
  • Laba, T., Brien, J., Jan, S. (2012). Understanding rational non-adherence to medications. A discrete choice experiment in a community sample in Australia. BMC Family Practice, 13, 1-10.

2011

  • Chaar, B., Brien, J., Hanrahan, J., McLachlan, A., Penm, J., Pont, L. (2011). Experimental Education in Australian Pharmacy: Preceptors' Perspectives. Pharmacy Education, 11(1), 166-171.
  • Yen, L., Gillespie, J., Jeon, Y., Kljakovic, M., Brien, J., Jan, S., Lehnbom, E., Pearce-Brown, C., Usherwood, T. (2011). Health professionals, patients and chronic illness policy: a qualitative study. Health expectations : an international journal of public participation in health care and health policy, 14(1), 10-20.
  • Aslani, P., Hogan, A., Brien, J., Bonney, M., Karamy, R. (2011). Nebulised medicine adherence and factors that affect adherence in patients with cystic fibrosis. Australasian Pharmaceutical Science Association (2011), Unkown.
  • Gallego, G., Taylor, S., Brien, J. (2011). Setting priorities for high-cost medications in public hospitals in Australia: should the public be involved? Australian Health Review, 35(2), 191-196.
  • Jan, S., Usherwood, T., Brien, J., Peiris, D., Rose, J., Hayman, N., Howard, K., Redfern, J., Laba, T., Cass, A., Patel, A. (2011). What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study. BMJ Open, 1(2), e000372-1-e000372-7.

2010

  • Lehnbom, E., Brien, J. (2010). Challenges in chronic illness management: a qualitative study of Australian pharmacists' perspectives. Pharmacy World and Science, 32(5), 631-636.
  • Sinha, Y., Craig, J., Barclay, P., Taitz, J., South, M., Coulthard, K., Pearson, C., Erickson, S., Brien, J. (2010). Drug approval processes in Australian Paediatric Hospitals. Archives of Disease in Childhood, 95(9), 739-744.

2009

  • Gallego, G., Taylor, S., Brien, J. (2009). Funding and access to high cost medicines in public hospitals in Australia: Decision-makers' perspectives. Health Policy, 92(1), 27-34.
  • Lehnbom, E., Welch, S., Ludington, J., Bryant, W., Brien, J. (2009). Impact of a New Insulin Chart on Hospitalised Patients with Diabetes. Journal of Pharmacy Practice and Research, 39(1), 45-49.
  • Lehnbom, E., Boxall, A., Russell, L., Brien, J. (2009). Management of Medicines in Chronic Illness: Views of Community Pharmacists in New South Wales. Journal of Pharmacy Practice and Research, 39(3), 207-210.
  • Chaar, B., Brien, J., Krass, I. (2009). Professional ethics in pharmacy practice: developing a psychometric measure of moral reasoning. Pharmacy World and Science, 31(4), 439-449.
  • Sweidan, M., Reeve, J., Brien, J., Jayasuriya, P., Martin, J., Vernon, G. (2009). Quality of drug interaction alerts in prescribing and dispensing software. Medical Journal of Australia, 190(5), 251-254.
  • Ellitt, G., Brien, J., Aslani, P., Chen, T. (2009). Quality Patient Care and Pharmacists' Role in Its Continuity - A Systematic Review. The Annals of Pharmacotherapy, 43(4), 677-691.
  • Sinha, Y., Brien, J., Craig, J. (2009). The pharmaceutical benefits scheme and implications for paediatric prescribing. Journal of Paediatrics and Child Health, 45(6), 351-357.

2008

  • Hargraves, T., Bennett, A., Brien, J. (2008). Developing an Outpatient Heart Failure Pharmacy Service. Journal of Pharmacy Practice and Research, 38(2), 103-106.
  • Brien, J. (2008). Keeping up with the evidence, trials and journals. Journal of Pharmacy Practice and Research, 38(2), 91-91.
  • O'Brien, R., Aslani, P., Ciccia, M., Brien, J. (2008). Medication adherence among heart and/or lung transplant recipients: An exploratory study. Patient Preference and Adherence, 2, 115-120.
  • Brien, J. (2008). Pharmacogenetics and the future of clinical pharmacy practice. Journal of Pharmacy Practice and Research, 38(1), 7-7.
  • Page, M., Bajorek, B., Brien, J. (2008). Prescribing in Teaching Hospitals: a Qualitative Study of Social and Cultural Dynamics. Journal of Pharmacy Practice and Research, 38(4), 286-291.
  • Brien, J. (2008). What is ethical research? Journal of Pharmacy Practice and Research, 38(3), 178-178.

2007

  • Moles, R., Brien, J., Benrimoj, S. (2007). New South Wales Private Hospitals and their Pharmacy Services. Journal of Pharmacy Practice and Research, 37(2), 115-119.
  • Gallego, G., Taylor, S., Brien, J. (2007). Priority setting for high cost medications (HCMs) in public hospitals in Australia: A case study. Health Policy, 84(1), 58-66.
  • Gallego, G., Taylor, S., Brien, J. (2007). Provision of pharmaceuticals in Australian hospitals: equity of access? Pharmacy World and Science, 29(2), 47-50.
  • Gallego, G., Taylor, S., McNeill, P., Brien, J. (2007). Public views on priority setting for High Cost Medications in public hospitals in Australia. Health expectations : an international journal of public participation in health care and health policy, 10(3), 224-235.

2006

  • Brien, J. (2006). Clinical governance. Journal of Pharmacy Practice and Research, 36(3), 174-174.
  • Chaar, B., Brien, J., Krass, I. (2006). Developing an instrument for measuring moral reasoning and professional ethics in pharmacy.
  • Bennett, A., Selim, L., Brien, J. (2006). Discharge evidence based medicine use after percutaneous coronary intervention. Asia Pacific Interventional Advances.
  • Hargraves, T., Bennett, A., Brien, J. (2006). Evaluating outpatient pharmacy services: a literature review of specialist heart failure services. International Journal of Pharmacy Practice, 14(1), 3-9.
  • Selim, L., Bennett, A., Brien, J. (2006). Evidence based medicine use in a high risk cardiovascular population. Australasian Pharmaceutical Sciences Association Annual Meeting.
  • Brien, J. (2006). Evidence-Based Practice. Journal of Pharmacy Practice and Research, 36(2), 94-95.
  • Welander, L., Bennett, A., Brien, J. (2006). Loop diuretic and spironolactone usage in hospitalised patients: A descriptive study. Society of Hospital Pharmacists of Australia, New South Wales State Branch Conference 'Mind the Gap'.
  • Bennett, A., Macdonald, P., Brien, J. (2006). Optimising medication management in cardiac patients: the impact of a specialist pharmacist. Heart Foundation Conference and Scientific Meeting.
  • Brien, J. (2006). Pharmaceutical Review- A View from academia. Journal of Pharmacy Practice and Research, 36(4), 256-256.
  • Kay, O., Bajorek, B., Brien, J. (2006). Pharmacist Prescribing Activities - An electronic survey on the opinions of Australian pharmacists from three pharmacy organisations. Journal of Pharmacy Practice and Research, 36(3), 199-203.
  • Brien, J. (2006). Planning the future. Journal of Pharmacy Practice and Research, 36(1), 10-10.
  • Tan, E., Day, R., Brien, J. (2006). Prioritising drug and therapeutics committee (DTC) decisions: a national survey. Pharmacy World and Science, published online 23 dec 2006 DOI 10.1007/s11096-00(29 (2007)), 90-96.
  • Selim, L., Bennett, A., Brien, J. (2006). Quality Use of Medicines in a high risk cardiovascular population. Society of Hospital Pharmacists of Australia, New South Wales State Branch Conference 'Mind the Gap'.
  • Chaar, B., Brien, J., Krass, I. (2006). The role of moral reasoning in the processes of decision making and professional ethics in the Quality Use of Medicines (QUM) and pharmacy. National Medicines Symposium 2006, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Gallego, G., Taylor, S., Brien, J. (2006). The role of the public in setting priorities in health care - high cost medications (HCMs) as a case study. Emerging Health Policy Conference,.
  • Bennett, A., Macdonald, P., Brien, J. (2006). The specialist cardiovascular pharmacist in chronic heart disease: an Australian perspective. European Society for Clinical Pharmacy. Vilnius,.

2005

  • Moles, R., Brien, J., Benrimoj, S. (2005). A medication education service (MES) provided to private hospital patients at discharge. Society of Hospital Pharmacists of Australia Federal Conference.
  • Gallego, G., Melocco, T., Taylor, S., Brien, J. (2005). Access to high cost drugs: decision makers' perspectives. Journal of Pharmacy Practice and Research, 35(1), 18-20.
  • Bennett, A., Jones, G., Macdonald, P., Brien, J. (2005). Additional benefits of follow-up NT-proBNP measurements in ambulatory heart failure patients after hospital discharge. Heart Failure Society of America.
  • Bennett, A., Hayward, C., Macdonald, P., Brien, J. (2005). Amiodarone-induced thyrotoxicosis (AIT): a challenge in heart failure (HF) patients. Society of Hospital Pharmacists of Australia Federal Conference.
  • Maxwell, D., Easton, K., Brien, J., Kaye, K. (2005). Antibiotic guidelines in NSW hospitals. Australian Health Review, 29(4), 416-421.
  • Bennett, A., Brien, J., Macdonald, P. (2005). Barriers To Diagnosing And Managing Heart Failure In Primary Care. Medical Journal of Australia, 182(6), 309-309.
  • Bennett, A., Jones, G., Macdonald, P., Brien, J. (2005). Comparison of BNP and NT-proBNP in prognostic determination of heart failure patients. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand.
  • Lehnbohn, E., Welch, S., Brien, J. (2005). Evaluation of a new insulin medication chart. Society of Hospital Pharmacists of Australia Federal Conference.
  • Slader, S., Welch, S., Finckh, A., Brien, J. (2005). Evaluation of a weight-based heparin dosing protocol. Journal of Pharmacy Practice and Research, 35(1), 15-17.
  • Gallego, G., Taylor, S., Brien, J. (2005). Paying for medicines used in hospitals in Australia. Federation Internationale Pharmaceutique (2005).
  • Tan, E., Day, R., Brien, J. (2005). Perspectives on Drug and Therapeutics Committee policy implementation. Research in Social and Administrative Pharmacy, 1(4), 526-545.
  • Chaar, B., Brien, J., Krass, I. (2005). Professional ethics in pharmacy: the Australian experience. International Journal of Pharmacy Practice, 13, 195-204.
  • Moles, R., Benrimoj, S., Brien, J. (2005). Professional Pharmacy Services to Private Hospital Patients 2005.
  • Moles, R., Brien, J., Benrimoj, S. (2005). S.I. Professional Pharmacy Services to Private Hospitals.
  • Hamama, A., Ray, J., Day, R., Brien, J. (2005). Simultaneous determination of rofecoxib and celecoxib in human plasma by high-performance liquid chromatography. Journal of Chromatographic Science, 43(7), 351-354.
  • Jones, E., Brien, J. (2005). Student assessment in clinical placements. Pharmacy Education Symposium.
  • Brien, J., Hall, W., Ward, R., Liauw, W., Lu, C. (2005). Tailoring access to high cost, genetically targeted drugs. Medical Journal of Australia, 182(12), 607-608.
  • Bennett, A., Krass, I., Brien, J. (2005). The future burden of cardiovascular disease: what can pharmacists do? Australian Journal of Pharmacy, 86(1020), 166-169.
  • Bennett, A., Jones, G., Macdonald, P., Brien, J. (2005). Within subject biological variation of N-terminal proB-type natriuretic peptide (NT-proBNP) in stable heart failure patients. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand.

2004

  • Moles, R., Brien, J., Benrimoj, S. (2004). A new Australian private hospital pharmacy service. Pharmacy and Pharmaceutical Sciences World Congress, 63rd Congress of Federation Internationale Pharmaceutique,.
  • Hamama, A., Ray, J., Liauw, W., Day, R., Brien, J. (2004). A population pharmacokinetics study of celecoxib and rofecoxib: a preliminary data analysis. Fourth Research Conference 2004 "From Cell to Society 4", Sydney: Faculties of Health, University of Sydney.
  • Hamama, A., Ray, J., LIAUW, W., Day, R., Brien, J. (2004). A population pharmacokinetics study of celecoxib and rofecoxib: preliminary model building. 2004 Australian Health and Medical Research Conference, Balnarring, Vic?: The Australian Health and Medical Research Congress.
  • Tan, E., Brien, J., Day, R. (2004). A qualitative investigation of Drug and Therapeutics Committee (DTC) policy implementation. 33rd European Symposium on Clinical Pharmacy: Risk Management in Pharmacotherapy.
  • Page, M., Bakorek, B., Brien, J. (2004). A qualitative study to explore influences on prescribing and how doctors learn to prescribe within teaching hospitals. Fourth Research Conference 2004 "From Cell to Society 4", Sydney: Faculties of Health, University of Sydney.
  • Gallego, G., Taylor, S., Brien, J. (2004). Access to high cost medicines (HCMs) in public hospitals: What does the general public know?. Australasian Pharmaceutical Science Association Conference, Melbourne, Vic: Australasian Pharmaceutical Science Association.
  • Maxwell, D., Kaye, K., Brien, J., Easton-Carter, K. (2004). Antibiotic guidelines - how far have we come?. National Medicines Symposium 2004 - Quality use of medicines: time for total integration. National Medicines Symposium 2004.
  • Tan, E., Day, R., Brien, J. (2004). Barriers to Drug and Therapeutics Committee (DTC) policy implementation. National Medicines Symposium 2004 - Quality use of medicines: time for total integration. National Medicines Symposium 2004.
  • Jones, G., Bennett, A., Boscato, L., Macdonald, P., Brien, J. (2004). Biological variation of N-Terminal Pro-BNP in Stable Heart failure. 42nd Annual Scientific Conference of the Australasian Association of Clinical Biochemists.
  • Jones, G., Boscato, L., Bennett, A., Macdonald, P., Brien, J. (2004). BNP storage stability and comparison with Pro-BNP in chronic heart failure. 42nd Annual Scientific Conference of the Australasian Association of Clinical Biochemists.
  • Maxwell, D., Kaye, K., Brien, J., Easton-Carter, K. (2004). Community acquired pneumonia: ceftriaxone and penicillin - A global perspective. Clinical Pharmacology and Toxicology World Congress.
  • Gallego, G., Taylor, S., Brien, J. (2004). Decision makers' perceptions of access to high cost drugs (HCDs) in public hospitals in Australia. ISPOR Ninth Annual International Meeting.
  • Gallego, G., Taylor, S., Brien, J. (2004). Decision-makers' perceptions of access to high cost medications (HCMs) in public hospitals. Fourth Research Conference 2004 "From Cell to Society 4", Sydney: Faculties of Health, University of Sydney.
  • Moles, R., Brien, J., Benrimoj, S. (2004). Development of a Medication Education Service for Private Hospital Patients. National Medicines Symposium 2004 - Quality use of medicines: time for total integration. National Medicines Symposium 2004.
  • Tan, E., Day, R., Brien, J. (2004). Drug and Therapeutics Committee (DTC) policy implementation: a qualitative study. 4th SHPA Biennial Clinical Conference.
  • Gilbar, P., Dooley, M., Brien, J. (2004). Editorial: Inadvertent intrathecal administration of vincristine: are we fulfilling our roles as oncology pharmacists? Journal of Oncology Pharmacy Practice, 10(4), 187-189.
  • Kay, O., Brien, J. (2004). editorial: Pharmacist prescribing - Lessons from abroad. Journal of Pharmacy Practice and Research, 34(4), 259-261.
  • Gallego, G., Taylor, S., Brien, J. (2004). Equity of access to high cost drugs (HCDs): A case study. Clinical Pharmacology and Toxicology World Congress.
  • Brien, J., Taylor, S., Gallego, G. (2004). Equity of access to oncology high cost drugs (HCDs): an Australian perspective. ISOPP IX : The Ninth International Symposium on Oncology Pharmacy Practice.
  • Slader, C., Welch, S., Finckh, A., Brien, J. (2004). Evaluation of a Weight-Based Heparin Dosing Protocol. National Medicines Symposium 2004 - Quality use of medicines: time for total integration. National Medicines Symposium 2004.
  • Sabet, P., Maxwell, D., Brien, J. (2004). Evaluation Of Mycophenolate For Unregistered Indications. Journal of Pharmacy Practice and Research, 34(1), 36-38.
  • Bennett, A., Hargraves, T., Macdonald, P., Brien, J. (2004). Evaluation of specialist pharmacy services. National Medicines Symposium 2004 - Quality use of medicines: time for total integration. National Medicines Symposium 2004.
  • Cocks, H., Kevans, P., Graham, R., Brien, J. (2004). Evaluation Of Therapeutic Drug Monitoring Services And Comparison Of Two Models Of Service Provision. Journal of Pharmacy Practice and Research, 34(2), 109-113.
  • Page, M., Bajorek, B., Brien, J. (2004). Exploring the influence of cultural and social factors in two teaching hospitals on the prescribing process and how doctors learn to prescribe. Young Pharmacists Conference.
  • Moles, R., Brien, J., Benrimoj, S. (2004). Factors influencing pharmaceutical service provision within NSW private hospitals. Australian Pharmacist, 23(3), 238-243.
  • Easton, K., Chapman, C., Brien, J. (2004). Frequency And Characteristics Of Hospital Admissions Associated With Drug-Related Problems In Paediatrics. British Journal of Clinical Pharmacology, 57(5), 611-615.
  • Gallego, G., Melocco, T., Taylor, S., Brien, J. (2004). Impact Of High Cost Drugs For Individual Patient Use. Journal of Pharmacy Practice and Research, 34(2), 100-103.
  • Bennett, A., Macdonald, P., Brien, J. (2004). Importance of pharmacist's role in multi-disciplinary care of heart failure (HF) patients. 4th SHPA Biennial Clinical Conference.
  • Gallego, G., Taylor, S., Melocco, T., Brien, J. (2004). Is equity of access to High Cost Drugs (HCDs) a QUM issue?. National Medicines Symposium 2004 - Quality use of medicines: time for total integration. National Medicines Symposium 2004.
  • Ellitt, G., Aslani, P., Brien, J., Whitehead, P., Ng, K., Chen, T. (2004). Is inter-disciplinary collaboration the answer to continuity of patient care?. From Cell to Society, College of Health Sciences, University of Sydney Research Conference.
  • Page, M., Brien, J., Bajorek, B. (2004). Medication management in teaching hospitals: a review of the role and practice of junior doctors. 4th SHPA Biennial Clinical Conference.
  • Bennett, A., Jones, E., Macdonald, P., Brien, J. (2004). NT-ProBNP as a prognostic marker in heart failure (HF) or risk stratification for HF patients using NT-proBNP. Australasian Pharmaceutical Science Association Conference, Melbourne, Vic: Australasian Pharmaceutical Science Association.
  • Lawler, C., Welch, S., Brien, J. (2004). Omitted Medication Doses: Frequency And Severity. Journal of Pharmacy Practice and Research, 34(3), 174-177.
  • Bennett, A., Macdonald, P., Brien, J. (2004). Optimal use of medications in heart failure (HF). Australasian Pharmaceutical Science Association Conference, Melbourne, Vic: Australasian Pharmaceutical Science Association.
  • Kay, O., Brien, J. (2004). Pharmacist prescribing- a review of the literature. 4th SHPA Biennial Clinical Conference.
  • Kay, O., Brien, J. (2004). Pharmacist prescribing: Review of the literature. Journal of Pharmacy Practice and Research, 34(4), 300-304.
  • Page, M., Bajorek, B., Brien, J. (2004). Prescribing in teaching hospitals: developing a qualitative instrument to explore influences on decisions and actions. Australasian Pharmaceutical Science Association Conference, Melbourne, Vic: Australasian Pharmaceutical Science Association.
  • Bennett, A., Bardsley,, K., Davidson, P., Macdonald, P., Brien, J. (2004). Quality Use of Medicines (QUM) in heart failure. ANZ Cardiac Society.
  • Bennett, A., Keogh, A., Brien, J. (2004). Ramifications of recent recommendations for high-dose statins: will we see more cases of myopathy?. 4th SHPA Biennial Clinical Conference.
  • Whitehead, P., Armour, C., Aslani, P., Brien, J., Chen, T., Loh, M., Sainsbury, E. (2004). Research Into Teaching: Quality Assurance In Clinical Placements. Australian Journal of Pharmacy, 85(1008), 166-169.
  • Tan, E., Day, R., Brien, J. (2004). Stakeholder opinions of Drug and Therapeutics Committee (DTC) policy implementation strategies. Clinical Pharmacology and Toxicology World Congress.
  • Tan, E., Day, R., Brien, J. (2004). Stakeholder Opinions On The Implementation Of Drug And Therapeutics Committee Decisions. Journal of Pharmacy Practice and Research, 34(3), 178-182.
  • Tan, E., Day, R., Brien, J. (2004). Strategies to implement Drug and Therapeutics Committee (DTC) decisions. Fourth Research Conference 2004 "From Cell to Society 4", Sydney: Faculties of Health, University of Sydney.
  • Bennett, A., Jones, G., Macdonald, P., Brien, J. (2004). Use of NT-proBNP as a prognostic marker in heart failure. From Cell to Society, College of Health Sciences, University of Sydney Research Conference.
  • Tan, E., Day, R., Brien, J. (2004). What makes a decision of a Drug & Therapeutics Committee 'important'?. Australasian Pharmaceutical Science Association Conference, Melbourne, Vic: Australasian Pharmaceutical Science Association.

2003

  • Sabet, P., Maxwell, D., Brien, J. (2003). A DUE of 'off-label' mycophenolate use at St. Vincent's Hospital. Society of Hospital Pharmacists of Australia, 26th Federal Conference.
  • Liao-Loon, H., Trayers, P., Bajorek, B., Brien, J. (2003). A feasibility study for the extension of professional pharmacy services to the Emergency Department of Nepean Hospital, focussing on pharmacist obtained medication histories (PIE study). Australasian Pharmaceutical Science Association Conference 2003, Not published: Icpof.
  • Hamama, A., Ray, J., LIAUW, W., Day, R., Brien, J. (2003). A population pharmacokinetics study of celecoxib and rofecoxib: a preliminary data analysis. Australasian Pharmaceutical Science Association Conference 2003, Not published: Icpof.
  • Gallego, G., Melocco, T., Taylor, S., Brien, J. (2003). Access to high cost drugs in public hospitals: the Australian scenario. Pharmacy and Pharmaceutical Sciences World Congress, 63rd Congress of Federation Internationale Pharmaceutique,.
  • Easton-Carter, K., Chapman, C., Brien, J. (2003). Adverse drug reactions in paediatrics: are we getting the full picture? Journal of Pharmacy Practice and Research, 33(2), 106-110.
  • Maxwell, D., Harkness, J., Brien, J. (2003). Antibiotic policy - The path of least resistance. Society of Hospital Pharmacists of Australia, 26th Federal Conference.
  • Gallego, G., Taylor, S., Melocco, T., Brien, J. (2003). Clinical decisions, ethical challenges: the role of a High Cost Drug Subcommittee (HCD). Society of Hospital Pharmacists of Australia, 26th Federal Conference.
  • Tan, E., Day, R., Campbell, T., Melocco, T., Brien, J. (2003). Drug and therapeutics committee (DTC) decision implementation: experiences at a teaching hospital. Pharmacy and Pharmaceutical Sciences World Congress, 63rd Congress of Federation Internationale Pharmaceutique,.
  • Tan, E., Day, R., Brien, J. (2003). Drug and therapeutics committees - are they fulfilling their potential to improve the quality use of medicines? International Journal of Pharmacy Practice, 11(3), 175-181.
  • Easton-Carter, K., Chapman, C., Brien, J. (2003). Emergency department attendances associated with drug-related problems in paediatrics. Journal of Paediatrics and Child Health, 39(2), 124-129.
  • Hargraves, T., Bennett, A., Brien, J. (2003). Evaluating specialist pharmacy (heart failure) ambulatory services. Australasian Pharmaceutical Science Association Conference 2003, Not published: Icpof.
  • Bennett, A., Brien, J., Macdonald, P., Bardsley,, K., Gay, T. (2003). Extended role for pharmacy to address continuity of care in chronic disease. Society of Hospital Pharmacists of Australia, 26th Federal Conference.
  • Tan, E., Day, R., Brien, J. (2003). From policy to practice: improving the effectiveness of Drug and Therapeutics Committee (DTC) decision implementation. Society of Hospital Pharmacists of Australia, 26th Federal Conference.
  • Gallego, G., Taylor, S., Melocco, T., Brien, J. (2003). High cost medications & decision makers. What's going on in Australia?. Australasian Pharmaceutical Science Association.
  • Bennett, A., Bardsley,, K., Gay, T., Macdonald, P., Brien, J. (2003). Home-based collaborative model for heart failure (HF) sufferers in Eastern Sydney. St Vincent's Hospital Campus Research Symposium.
  • Tan, E., Day, R., Brien, J. (2003). Improving decision outcomes of drug and therapeutics committees. Journal of Pharmacy Practice and Research, 33(1), 65-67.
  • Moles, R., Brien, J., Benrimoj, S. (2003). M.E.S. - a new private hospital service. Australasian Pharmaceutical Science Association Conference 2003, Not published: Icpof.
  • O'Brien, R., Ciccia, M., Aslani, P., Brien, J. (2003). Medication adherence in heart lung transplant recipients. Society of Hospital Pharmacists of Australia, 26th Federal Conference.
  • Moles, R., Brien, J., Benrimoj, S. (2003). Medication education and medication review services to private hospital patients. Society of Hospital Pharmacists of Australia, 26th Federal Conference.
  • Brien, J. (2003). Pharmacogenomics - clinical and social implications. Journal of Pharmacy Practice and Research, 33(3), 224-227.
  • Chaar, B., Brien, J., Krass, I. (2003). Professional ethics in pharmacy. Australian Journal of Pharmacy, 84, 856-859.
  • Bennett, A., Bardsley,, K., Macdonald, P., Brien, J. (2003). Providing support for community pharmacists caring for heart failure patients. Pharmacy and Pharmaceutical Sciences World Congress, 63rd Congress of Federation Internationale Pharmaceutique,.
  • Aslani, P., Armour, C., Brien, J., Chen, T., Loh, M., Moles, R., Sainsbury, E., Whitehead, P. (2003). Quality Assurance in Experiential Learning. EdHealth Conference,, sydney: University of Sydney.
  • Armour, C., Aslani, P., Brien, J., Chen, T., Loh, M., Moles, R., Sainsbury, E. (2003). Quality assuring clinical placements. Australasian Pharmaceutical Science Association Conference 2003, Not published: Icpof.
  • Sainsbury, E., Armour, C., Aslani, P., Brien, J., Chen, T., Moles, R., Singh, P., Loh, M., Whitehead, P. (2003). You just won't believe what happened in my placement yesterday! Experiences of a novel clinical placement program in final year pharmacy. Annual meeting of Higher Education Research and Development Society of Australasia, notk known.
  • Whitehead, P., Loh, M., Sainsbury, E., Aslani, P., Brien, J., Chen, T., Moles, R., Singh, P., Armour, C. (2003). You'll never guess what happened in my placement yesterday. Vice-Chancellor's teaching and learning showcase of scholarly reflection and inquiry.

2002

  • Hamama, A., Day, R., Brien, J., Ray, J. (2002). An innovative assay for the simultaneous quantitation of rofecoxib and celecoxib in human plasma. Annual Conference of the Australasian Pharmaceutical Science Association. Australasian Pharmaceutical Science Association.
  • Moles, R., Benrimoj, S., Brien, J. (2002). Census of pharmacy models and services in New South Wales private hospitals. Society of Hospital Pharmacists of Australia, NSW State Branch Conference. The Society of Hospital Pharmacists of Australia.
  • Bennett, A., Brien, J. (2002). Community liaison pharmacist role in the multi-disciplinary care of heart failure patients. Australian Journal of Pharmacy, 83, 740-743.
  • Tan, E., Day, R., Brien, J. (2002). Current principle functions of drugs and therapeutics committees. 12th International Social Pharmacy Workshop, Sydney: Faculty of Pharmacy, University of Sydney.
  • Brien, J., Mant, A., Kaye, K., Kehoe, P. (2002). Evaluation of the implementation and effectiveness of the Australian Pharmaceutical Advisory Committee Guidelines to achieve the continuum of quality use of medicines between hospital and community.
  • Bennett, A., Brien, J., Macdonald, P., Bardsley,, K., Jones, G., Hayward, C., Keogh, A., Campbell, T. (2002). Identification and management of high risk heart failure patients using BNP. 12th St Vincent's and Mater Health Research Conference, Sydney Australia.
  • Tan, E., Brien, J., Day, R. (2002). Implementation of Drug and Therapeutics Committee decisions: interventions to influence prescribing. Annual Conference of the Australasian Pharmaceutical Science Association. Australasian Pharmaceutical Science Association.
  • Moles, R., Benrimoj, S., Brien, J. (2002). Implementing professional services in NSW private hospitals: work in progress. Society of Hospital Pharmacists of Australia, NSW State Branch Conference. The Society of Hospital Pharmacists of Australia.
  • Easton-Carter, K., Chapman, C., Brien, J. (2002). Issues in the interpretation and design of studies investigating drug-related morbidity and mortality. Journal of Pharmacy Practice and Research, 32(3), 235-239.
  • Bennett, A., Brien, J., Bardsley,, K., Macdonald, P. (2002). Optimisation of heart failure management by pharmacists. Society of Hospital Pharmacists of Australia, NSW State Branch Conference. The Society of Hospital Pharmacists of Australia.
  • Bennett, A., Brien, J., Macdonald, P., Bardsley,, K. (2002). Pharmacist involvement in the multidisciplinary management of heart failure.
  • Moles, R., Benrimoj, S., Brien, J. (2002). Pharmacists' views on implementing professional pharmacy services in NSW private hospitals. 3rd Annual College of Health Science Research Conference, Sydney: University of Sydney.
  • Tan, E., Day, R., Brien, J. (2002). QUM and the Drug Committee: current principle functions of DTCs. Society of Hospital Pharmacists of Australia, NSW State Branch Conference. The Society of Hospital Pharmacists of Australia.
  • Bennett, A., Brien, J., Bardsley,, K., Macdonald, P. (2002). Research opportunities in an innovative service program. Annual Conference of the Australasian Pharmaceutical Science Association. Australasian Pharmaceutical Science Association.
  • Gallego, G., Brien, J., Taylor, S., Melocco, T. (2002). The financial impact of approval of high cost drugs for individual patient use (IPU) at a Sydney teaching hospital. Society of Hospital Pharmacists of Australia, NSW State Branch Conference. The Society of Hospital Pharmacists of Australia.
  • Slader, C., Brien, J. (2002). The graduates forum: supporting new graduates in the transition from university to hospitals. Society of Hospital Pharmacists of Australia, NSW State Branch Conference. The Society of Hospital Pharmacists of Australia.

2001

  • Easton-Carter, K., Brien, J., Kay, K., Mackson, J., Robinson, M., Day, R., New South Wales Therapeutic Assessment Group, D. (2001). A multi-centre drug use evaluation study of proton pump inhibitor prescribing. Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists Conference. World Scientific Publishing.
  • Easton-Carter, K., Kaye, K., Mackson, J., Robinson, M., Brien, J., New South Wales Therapeutic Assessment Group, D. (2001). A multicentre investigation of the prescribing of proton pump inhibitors in hospitals. St Vincent's Hospital Research Symposium.
  • Carapetis, J., jaquiery, A., Buttery, J., Starr, M., Hogg, G., Woods, S., Cranswick, N., Kohn, S., Brien, J., Grimwood, K. (2001). A randomised, controlled trial of once-daily gentamicin in children with urinary tract infections. The Pediatric Infectious Disease Journal, 20(3), 240-246.
  • Bennett, A., Brien, J. (2001). Advances in heart failure management: a review of recent research and a future role for pharmacists. Part 1. Australian Journal of Pharmacy, 82, 716-719.
  • Bennett, A., Brien, J. (2001). Advances in heart failure management: a review of recent research and a future role for pharmacists. Part 2. Australian Journal of Pharmacy, 82, 830-835.
  • Kaye, K., Easton-Carter, K., Mackson, J., Robinson, M., Day, R., Brien, J. (2001). An Investigation of Hospital Prescribing of Proton Pump Inhibitors. Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists Conference. World Scientific Publishing.
  • Easton-Carter, K., Kaye, K., Mackson, J., Robinson, M., Brien, J., New South Wales Therapeutic Assessment Group, D. (2001). Consistency of proton pump inhibitor prescribing with guidelines: a multicentre drug use evaluation study. Society of Hospital Pharmacists of Australia 25th Federal Conference.
  • Brien, J., Tan, E., Day, R. (2001). Drug and therapeutic committee performance evaluation. Australian Pharmaceutical Science Association Conference, : World Scientific Publishing.
  • Tan, E., Easton-Carter, K., Lawler, C., Jan, D., Mohammed Abdul, M., Melocco, T., Day, R., Brien, J. (2001). Drug committee activities to ensure the quality use of medicines. St Vincent's Hospital Research Symposium.
  • Easton-Carter, K., Kaye, K., Mackson, J., Robinson, M., Brien, J. (2001). Drug Utilisation Support Group. Consistency of proton pump inhibitor prescribing with guidelines: a multicentre drug use evaluation study. Society of Hospital Pharmacists of Australia 25th Federal Conference.
  • Tan, E., Day, R., Melocco, T., Brien, J. (2001). How to assess outcomes of drug and therapeutics committees. Society of Hospital Pharmacists of Australia 25th Federal Conference.
  • Brien, J., Bennett, A., Macdonald, P., Bardsley,, K., Jones, G., Hayward, C., Keogh, A., Campbell, T. (2001). Optimal long term treatment of congestive heart failure (CHF) patients. Australian Pharmaceutical Science Association Conference, : World Scientific Publishing.
  • Easton-Carter, K., Brien, J., Kaye, K., Mackson, J., Robinson, M., Day, R. (2001). Undertaking multicentre drug use evaluation studies: the proton pump inhibitor (PPI) experience. Australian Pharmaceutical Science Association Conference, : World Scientific Publishing.
Back to Top

Keywords

Health practice

Back to Top

For support on your academic profile contact Research Support.